Effect of change in symptoms, respiratory status, nutritional profile and quality of life on response to treatment for advanced non-small cell lung cancer

Asian Pacific Journal of Cancer Prevention

Volumn 9, Issue 4, 2008, Pages 557-562

  Mohan, Anant ^a   Singh, P ^a   Kumar, S ^a   Mohan, C ^a   Pathak, A K ^a   Pandey, R M ^a   Guleria, R ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Chemotherapy; Lung cancer; Nutrition; Quality of life

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER INVASION; CANCER STAGING; CHI SQUARE DISTRIBUTION; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HUMAN; LUNG FUNCTION TEST; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NUTRITIONAL STATUS; PATHOLOGY; PROBABILITY; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RISK ASSESSMENT; SPIROMETRY; SURVIVAL; TREATMENT FAILURE; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NUTRITIONAL STATUS; PROBABILITY; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; RESPIRATORY FUNCTION TESTS; RISK ASSESSMENT; SPIROMETRY; SURVIVAL ANALYSIS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 66149116892     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Aaronson NK, Ahmedzai S, Bergman B, et al (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst, 85, 365-76.
2. Belani CP, Pereira JR, von Pawel J, et al (2006). Effect of chemotherapy for advanced non-small cell lung cancer on patients' quality of life. A randomized controlled trial. Lung Cancer, 53, 231-9.
3. Bernhard J, Ganz PA (1991). Psychosocial issues in lung cancer patients (Part 1). Chest, 99, 216-23.
4. Bestall JC, Paul EA, Garrod R, et al (1999). Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax, 54, 581-6.
5. Bonomi P, Kim K, Fairclough D, et al (2000). Comparison of survival and quality of life in advanced non-small-cell lung cancer patients treated with two dose levels of paclitaxel combined with cisplatin versus etoposide with cisplatin: results of an Eastern Cooperative Oncology Group trial. J Clin Oncol, 18, 623-31.
6. Brooks D, Solway S, Gibbons WJ (2003). ATS statement on six-minute walk test. Am J Respir Crit Care Med, 167, 1287.
7. Brown JK, Radke KJ (1998). Nutritional assessment, intervention, and evaluation of weight loss in patients with non-small cell lung cancer. Oncol Nurs Forum, 25, 547-53.
8. Buccheri G, Ferrigno D (1994). Prognostic factors in lung cancer: tables and comments. Eur Respir J, 7, 1350-64.
9. Buccheri G, Ferrigno D (2001). Importance of weight loss definition in the prognostic evaluation of non-small-cell lung cancer. Lung Cancer, 34, 433-40.
10. Buccheri GF, Ferrigno D, Tamburini M, Brunelli C (1995). The patient's perception of his own quality of life might have an adjunctive prognostic significance in lung cancer. Lung Cancer, 12, 45-58.
11. Cooley ME (2000). Symptoms in adults with lung cancer. A systematic research review. J Pain Symptom Manage, 19, 137-53.
12. Crapo RO, Morris AH, Gardner RM (1981). Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis, 123, 659-64.
13. Davidson JT, Whipp BJ, Wasserman K, Koyal SN, Lugliani R (1974). Role of the carotid bodies in breath-holding. N Engl J Med, 290, 819-22.
14. Ganz PA, Figlin RA, Haskell CM, La Soto N, Siau J (1989). Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Does chemotherapy make a difference? Cancer, 63, 1271-8.
15. Gopal R, Starkschall G, Tucker SL, et al (2003). Effects of radiotherapy and chemotherapy on lung function in patients with non-small-cell lung cancer. Int J Radiat Oncol Biol Phys, 56, 114-20.
16. Groen HJ, van der Mark TW, van der Leest AH, de Vries EG, Mulder NH (1995). Pulmonary function changes in lung-cancer patients treated with radiation with or without carboplatin. Am J Respir Crit Care Med, 152, 2044-8.
17. Hopwood P, Stephens RJ (1995). Symptoms at presentation for treatment in patients with lung cancer: implications for the evaluation of palliative treatment. The Medical Research Council (MRC) Lung Cancer Working Party. Br J Cancer, 71, 633-6.
18. Ide S (2001). Fever and survival with drug-treated non-small cell lung cancer. Kurume Med J, 48, 9-14.
19. Khalid U, Spiro A, Baldwin C, et al (2007). Symptoms and weight loss in patients with gastrointestinal and lung cancer at presentation. Support Care Cancer, 15, 39-46.
20. Koyama H, Nishimura K, Ikeda A, Tsukino M, Izumi T (1998). A comparison of different methods of spirometric measurement selection. Respir Med, 92, 498-504.
21. Lassen U, Osterlind K, Hansen M, et al (1995). Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years-an analysis of 1,714 consecutive patients. J Clin Oncol, 13, 1215-20.
22. Maas KW, van der Lee I, Bolt K, et al (2003). Lung function changes and pulmonary complications in patients with stage III non-small cell lung cancer treated with gemcitabine/ cisplatin as part of combined modality treatment. Lung Cancer, 41, 345-51.
23. Mador MJ, Kufel TJ (1992). Reproducibility of visual analog scale measurements of dyspnea in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis, 146, 82-7.
24. Mahler DA, Wells CK (1988). Evaluation of clinical methods for rating dyspnea. Chest, 93, 580-6.
25. Mahler DA, Faryniarz K, Tomlinson D, et al (1992). Impact of dyspnea and physiologic function on general health status in patients with chronic obstructive pulmonary disease. Chest, 102, 395-401.
26. McGavin CR, Artvinli M, Naoe H, McHardy GJ (1978), Dyspnoea, disability, and distance walked: comparison of estimates of exercise performance in respiratory disease. BMJ, 2, 241-3.
27. Mohan A, Mohan C, Pathak AK, Pandey RM, Guleria R (2007). Impact of chronic obstructive pulmonary disease on respiratory status and quality of life in newly diagnosed patients with lung cancer. Respirology, 12, 240-7.
28. Mohan A, Singh P, Singh S, et al (2007). Quality of life in lung cancer patients: impact of baseline clinical profile and respiratory status. Eur J Cancer Care, 16, 268-76.
29. Moinpour CM, Lyons B, Grevstad PK, et al (2002). Quality of life in advanced non-small-cell lung cancer: results of a Southwest Oncology Group randomized trial. Qual Life Res, 11, 115-26.
30. Montazeri A, Milroy R, Hole D, McEwen J, Gillis CR (2001). Quality of life in lung cancer patients: as an important prognostic factor. Lung Cancer, 31, 233-40.
31. Montazeri A, Milroy R, Hole D, McEwen J, Gillis CR (2003). How quality of life data contribute to our understanding of cancer patients' experiences? A study of patients with lung cancer. Qual Life Res, 12, 157-66.
32. Mountain CF (1997). Revisions in the International System for Staging Lung Cancer. Chest, 111, 1710-7.
33. Mungall IP, Hainsworth R (1979). Assessment of respiratory function in patients with chronic obstructive airways disease. Thorax, 34, 254-8.
34. Naughton MJ, Herndon JE, 2nd, Shumaker SA, et al (2002). The health-related quality of life and survival of small-cell lung cancer patients: results of a companion study to CALGB 9033. Qual Life Res, 11, 235-48.
35. Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA Cancer J Clin Oncol, 55, 74-108.
36. Pinson P, Klastersky J (1998). The value of lung function measurements for the assessment of chemotherapy in lung cancer patients. Lung Cancer, 19, 179-84.
37. Prasad R, James P, Kesarwani V, et al (2004). Clinicopathological study of bronchogenic carcinoma. Respirology, 9, 557-60.
38. Saxena S, Chandiramani K, et al (1998). WHOQOL-Hindi: a questionnaire for assessing quality of life in health care settings in India. World Health Organization Quality of Life. Natl Med J India, 11, 160-5.
39. Schaafsma J, Osoba D (1994). The Karnofsky Performance Status Scale re-examined: a cross-validation with the EORTC-C30. Qual Life Res, 3, 413-24.
40. Spiro SG, Rudd RM, Souhami RL, et al (2004). Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life. Thorax, 59, 828-36.
41. Svobodnik A, Yang P, Novotny PJ, et al (2004). Quality of life in 650 lung cancer survivors 6 months to 4 years after diagnosis. Mayo Clin Proc, 79, 1024-30.
42. Zhou SW, Ren SX, et al (2008). Impact of erlotinib treatment on symptoms and quality of life in patients with advanced non-small-cell lung cancer. Zhonghua Zhong Liu Za Zhi, 30, 469-72 (in Chinese).